TY - JOUR
T1 - Guidelines for the genetic diagnosis of hereditary recurrent fevers
AU - Shinar, Y.
AU - Obici, L.
AU - Aksentijevich, I.
AU - Bennetts, B.
AU - Austrup, F.
AU - Ceccherini, I.
AU - Costa, J. M.
AU - De Leener, A.
AU - Gattorno, M.
AU - Kania, U.
AU - Kone-Paut, I.
AU - Lezer, S.
AU - Livneh, A.
AU - Moix, I.
AU - Nishikomori, R.
AU - Ozen, S.
AU - Phylactou, L.
AU - Risom, L.
AU - Rowczenio, D.
AU - Sarkisian, T.
AU - Van Gijn, M. E.
AU - Witsch-Baumgartner, M.
AU - Morris, M.
AU - Hoffman, H. M.
AU - Touitou, Isabelle
PY - 2012/10
Y1 - 2012/10
N2 - Hereditary recurrent fevers (HRFs) are a group of monogenic autoinflammatory diseases characterised by recurrent bouts of fever and serosal inflammation that are caused by pathogenic variants in genes important for the regulation of innate immunity. Discovery of the molecular defects responsible for these diseases has initiated genetic diagnostics in many countries around the world, including the Middle East, Europe, USA, Japan and Australia. However, diverse testing methods and reporting practices are employed and there is a clear need for consensus guidelines for HRF genetic testing. Draft guidelines were prepared based on current practice deduced from previous HRF external quality assurance schemes and data from the literature. The draft document was disseminated through the European Molecular Genetics Quality Network for broader consultation and amendment. A workshop was held in Bruges (Belgium) on 18 and 19 September 2011 to ratify the draft and obtain a final consensus document. An agreed set of best practice guidelines was proposed for genetic diagnostic testing of HRFs, for reporting the genetic results and for defining their clinical significance.
AB - Hereditary recurrent fevers (HRFs) are a group of monogenic autoinflammatory diseases characterised by recurrent bouts of fever and serosal inflammation that are caused by pathogenic variants in genes important for the regulation of innate immunity. Discovery of the molecular defects responsible for these diseases has initiated genetic diagnostics in many countries around the world, including the Middle East, Europe, USA, Japan and Australia. However, diverse testing methods and reporting practices are employed and there is a clear need for consensus guidelines for HRF genetic testing. Draft guidelines were prepared based on current practice deduced from previous HRF external quality assurance schemes and data from the literature. The draft document was disseminated through the European Molecular Genetics Quality Network for broader consultation and amendment. A workshop was held in Bruges (Belgium) on 18 and 19 September 2011 to ratify the draft and obtain a final consensus document. An agreed set of best practice guidelines was proposed for genetic diagnostic testing of HRFs, for reporting the genetic results and for defining their clinical significance.
UR - http://www.scopus.com/inward/record.url?scp=84866132717&partnerID=8YFLogxK
U2 - 10.1136/annrheumdis-2011-201271
DO - 10.1136/annrheumdis-2011-201271
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.systematicreview???
AN - SCOPUS:84866132717
SN - 0003-4967
VL - 71
SP - 1599
EP - 1605
JO - Annals of the Rheumatic Diseases
JF - Annals of the Rheumatic Diseases
IS - 10
ER -